Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8075884 Antibodies to OX-2/CD200 and uses thereof

Patent 8075884 was granted and assigned to Alexion Pharmaceuticals, Inc. on December, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

80758840

Patent Inventor Names

Anke Kretz-Rommel0

Dayang Wu0

Jeremy P. Springhorn0

Katherine S. Bowdish0

Susan Faas McKnight0

Date of Patent

December 13, 2011

Patent Application Number

120876830

Date Filed

January 11, 2007

Patent Citations Received

‌

US Patent 11773173 Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient

‌

US Patent 11802154 Humanized anti-CD200 antibodies and uses thereof

‌

US Patent 11761963 Biomarker signature for predicting tumor response to anti-CD200 therapy

Patent Primary Examiner

‌

Ilia Ouspenski

Patent abstract

This application provides methods and compositions for modulating and/or depleting CD200 positive cells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8075884 Antibodies to OX-2/CD200 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API